Elsherbeny, Mohamed H. Ammar, Usama M. Abdellattif, Magda H. Abourehab, Mohammed A. S. Abdeen, Ahmed Ibrahim, Samah F. Abdelrahaman, Doaa Mady, Wessam Roh, Eun Joo Elkamhawy, Ahmed 2024-11-07T01:30:51Z 2024-11-07T01:30:51Z 2024-11-06 2024-04 0024-3019 https://pubs.kist.re.kr/handle/201004/150984 In the original publication [1], reference number 26 [2] was added by mistake. Thus, it was removed. With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. English Multidisciplinary Digital Publishing Institute (MDPI) 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation (vol 12, 8Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 87676, 2022) Article 10.3390/life14040423 1 Life, v.14, no.4 Life 14 4 Y scie scopus 001316034800001 2-s2.0-85193214591 Biology Microbiology Life Sciences & Biomedicine - Other Topics Microbiology Correction